Stockreport

Xenon Remains Well-Positioned And Well-Funded Despite COVID-19 Related Setbacks [Seeking Alpha]

Neurocrine Biosciences, Inc.  (NBIX) 
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: neurocrine.com/about-us/webcasts-presentations
PDF SummaryXenon Pharmaceuticals recently provided a corporate update in the context of COVID-19.In it, the company highlights its advantageous cash flow and runway.Furtherm [Read more]